NYSE:SOLVMedical Equipment
Solventum (SOLV) Stock May Trade At A Discount After 13% Gain
Solventum stock has quietly put up a 13.1% return over the past year, and the valuation checks now suggest the shares lean toward the cheaper side rather than looking stretched after that move.
Over the past 12 months Solventum has returned 13.1%, which is enough to make the current pricing worth a closer look rather than assuming it is either a bargain or overheated.
The planned separation of the Health Information Systems software business may support a sharper focus on MedTech returns...